% For this appendix, undo tufte-latex's big margin
\newgeometry{left=1in,right=1in,bottom=1.5in,textwidth=6.5in,marginparsep=0pc,marginparwidth=0pc}
% Recalculate fancy header/footer after geometry change (otherwise page numbers are misplaced)
\fancyhfoffset[E,O]{0pt}

\chapter{Appendix Tables}

\begin{flushleft}
\small

\begin{longtable}[l]{l P{9cm}}
    \toprule
    Variable & Description \\
    \midrule
  \endhead
    \caption[Close correlates for \emph{C. difficile} infection that were excluded from propensity modeling]{\textbf{Variables closely correlated with \emph{Clostridium difficile} infection workup or treatment that were excluded from propensity modeling in Chapter \ref{chap:cdi_cost}.} Raw data for this table are available in tab-separated values format from Figshare at \textsc{doi}:~\href{http://dx.doi.org/10.6084/m9.figshare.4311695}{\texttt{10.6084/m9.figshare.4311695}}. Abbreviation: C.DIFF, Clostridium difficile; PCR, polymerase chain reaction; EIA, enzyme immunoassay; CAP, caplet; TAB, tablet; ISO-OSM, iso-osmotic; IV, intravenous; SUSP, suspension}
    \\
    \toprule
    Variable & Description \\
    \midrule
  \endfirsthead
    \midrule
    \multicolumn{2}{r}{\textit{Continued on next page\ldots}} \\
  \endfoot
    \bottomrule
  \endlastfoot
    problem\textunderscore list:008.45 & Intestinal infection due to Clostridium difficile \\
    abnormal\textunderscore labs:4730 & C.DIFF. TOXIN B PCR \\
    abnormal\textunderscore labs:4647 & C.DIFF EIA \\
    abnormal\textunderscore labs:4647 & C.DIFF EIA TOXIN A\&B \\
    meds\textunderscore administered:300025 & VANCOMYCIN ORAL LIQUID REPACKAGE ONLY - 125MG/2.5ML \\
    meds\textunderscore administered:63653  & VANCOMYCIN ORAL \\
    meds\textunderscore administered:8200 & VANCOMYCIN 125 MG CAP \\
    meds\textunderscore administered:14246 & VANCOMYCIN 250 MG/5 ML ORAL SOLUTION \\
    meds\textunderscore administered:300092 & VANCOMYCIN ENEMA \\
    meds\textunderscore administered:13623 & VANCOMYCIN 250 MG CAP \\
    meds\textunderscore administered:5484 & METRONIDAZOLE 250 MG TAB \\
    meds\textunderscore administered:54227 & METRONIDAZOLE ORAL \\
    meds\textunderscore administered:6870 & METRONIDAZOLE 500 MG TAB \\
    meds\textunderscore administered:5484 & METRONIDAZOLE 250 MG TAB \\
    meds\textunderscore administered:6295 & METRONIDAZOLE IN SODIUM CHLORIDE (ISO-OSM) 500 MG/100 ML IV PIGGY BACK \\
    meds\textunderscore administered:400648 & METRONIDAZOLE 250 MG/50 ML ISO-OSMOTIC SOLUTION \\
    meds\textunderscore administered:1527 & METRONIDAZOLE HCL 500 MG IV SOLUTION \\
    meds\textunderscore administered:19702 & METRONIDAZOLE 375 MG CAP \\
    meds\textunderscore administered:300009 & METRONIDAZOLE 50 MG/ML ORAL SUSP \\
    meds\textunderscore administered:400660 & METRONIDAZOLE 750 MG/150 ML ISO-OSMOTIC SOLUTION \\
    meds\textunderscore reported:300025 & VANCOMYCIN ORAL LIQUID REPACKAGE ONLY - 125MG/2.5ML \\
    meds\textunderscore administered:14246 & VANCOMYCIN 250 MG/5 ML ORAL SOLUTION \\
    meds\textunderscore administered:300092 & VANCOMYCIN ENEMA \\
    meds\textunderscore administered:13623 & VANCOMYCIN 250 MG CAP \\
    meds\textunderscore administered:5484 & METRONIDAZOLE 250 MG TAB \\
    meds\textunderscore administered:54227 & METRONIDAZOLE ORAL \\
    meds\textunderscore administered:6870 & METRONIDAZOLE 500 MG TAB \\
    meds\textunderscore administered:5484 & METRONIDAZOLE 250 MG TAB \\
    meds\textunderscore administered:6295 & METRONIDAZOLE IN SODIUM CHLORIDE (ISO-OSM) 500 MG/100 ML IV PIGGY BACK \\
    meds\textunderscore administered:400648 & METRONIDAZOLE 250 MG/50 ML ISO-OSMOTIC SOLUTION \\
    meds\textunderscore administered:1527 & METRONIDAZOLE HCL 500 MG IV SOLUTION \\
    meds\textunderscore administered:19702 & METRONIDAZOLE 375 MG CAP \\
    meds\textunderscore administered:300009 & METRONIDAZOLE 50 MG/ML ORAL SUSP \\
    meds\textunderscore administered:400660 & METRONIDAZOLE 750 MG/150 ML ISO-OSMOTIC SOLUTION \\
    meds\textunderscore reported:300025 & VANCOMYCIN ORAL LIQUID REPACKAGE ONLY - 125MG/2.5ML \\
    meds\textunderscore reported:63653  & VANCOMYCIN ORAL \\
    meds\textunderscore reported:8200 & VANCOMYCIN 125 MG CAP \\
    meds\textunderscore reported:14246 & VANCOMYCIN 250 MG/5 ML ORAL SOLUTION \\
    meds\textunderscore reported:300092 & VANCOMYCIN ENEMA \\
    meds\textunderscore reported:13623 & VANCOMYCIN 250 MG CAP \\
    meds\textunderscore reported:5484 & METRONIDAZOLE 250 MG TAB \\
    meds\textunderscore reported:54227 & METRONIDAZOLE ORAL \\
    meds\textunderscore reported:6870 & METRONIDAZOLE 500 MG TAB \\
    meds\textunderscore reported:5484 & METRONIDAZOLE 250 MG TAB \\
    meds\textunderscore reported:6295 & METRONIDAZOLE IN SODIUM CHLORIDE (ISO-OSM) 500 MG/100 ML IV PIGGY BACK \\
    meds\textunderscore reported:400648 & METRONIDAZOLE 250 MG/50 ML ISO-OSMOTIC SOLUTION \\
    meds\textunderscore reported:1527 & METRONIDAZOLE HCL 500 MG IV SOLUTION \\
    meds\textunderscore reported:19702 & METRONIDAZOLE 375 MG CAP \\
    meds\textunderscore reported:300009 & METRONIDAZOLE 50 MG/ML ORAL SUSP \\
    meds\textunderscore reported:400660 & METRONIDAZOLE 750 MG/150 ML ISO-OSMOTIC SOLUTION \\
    problem\textunderscore list:041.84 & Other specified bacterial infections in conditions classified elsewhere and of unspecified site, other anaerobes \\
    problem\textunderscore list:V07.0 & Need for isolation \\
    problem\textunderscore list:V02.3 & Carrier or suspected carrier of other gastrointestinal pathogens \\
    problem\textunderscore list:787.91 & Diarrhea \\
    \label{tab:excluded_vars}
\end{longtable}
\end{flushleft}

\begin{table*}[hp]
  \fullwidthlabelcaption{tab:chik_antibodies}{Antibodies used for CyTOF analysis}{
    \small
    \textbf{Antibodies used for CyTOF analysis in Chapter \ref{chap:chik}}. All antibodies were either purchased directly from Fluidigm or conjugated in-house using X8 conjugation kits. \vspace{1em}
  }
  \small
  \begin{tabular}{l l l l}
    \toprule
    Isotope & Target & Clone & Source \\
    \midrule
    113 In & CD57 & HCD57 & Biolegend \\
    115 In & CD45 & HI130 & Biolegend \\
    142 Nd & CD19 & HIB19 & Biolegend \\
    143 Nd & CD45RA & HI100 & Biolegend \\
    144 Nd & CD141 & M80 & Biolegend \\
    145 Nd & CD4 & RPA-T4 & Biolegend \\
    146 Nd & CD8 & RPA-T8 & Biolegend \\
    147 Sm & CD20 & 2H7 & Fluidigm \\
    148 Nd & CD16 & 3G8 & Biolegend \\
    149 Sm & CD127 & A019D5 & Biolegend \\
    150 Nd & CD1c & L161 & Biolegend \\
    151 Eu & CD123 & 6H6 & Biolegend \\
    152 Sm & CD66b & G10F5 & Biolegend \\
    153 Eu & CXCR5 & RF8B2 & Fluidigm \\
    154 Sm & CD86 & IT2.2 & Biolegend \\
    155 Gd & CD27 & O323 & Biolegend \\
    156 Gd & CCR5 & NP-6G4 & Fluidigm \\
    158 Gd & CHIKV & ? & ? \\
    159 Tb & CD11c & Bu15 & Fluidigm \\
    160 Gd & CD14 & M5E2 & Biolegend \\
    161 Dy & CD56 & B159 & BD Biosciences \\
    162 Dy & CD80 & 2D10.4 & Fluidigm \\
    163 Dy & CCR4 & 205410 & R\&D Systems \\
    164 Dy & CD40 & 5C3 & Biolegend \\
    165 Ho & CCR6 & G034E3 & Biolegend \\
    166 Er & CD25 & M-A251 & Biolegend \\
    167 Er & CCR7 & G043H7 & Biolegend \\
    168 Er & CD3 & UCHT1 & Biolegend \\
    169 Tm & CX3CR1 & 2A9-1 & Biolegend \\
    170 Er & CD38 & HB-7 & Biolegend \\
    171 Yb & CD161 & HP-3G10 & Biolegend \\
    172 Yb & CD209 & 9E9A8 & Biolegend \\
    173 Yb & CXCR3 & G025H7 & Biolegend \\
    174 Yb & HLADR & L243 & Biolegend \\
    175 Lu & PD-1 & EH12.2H7 & Fluidigm \\
    176 Yb & CD54 & HCD54 & Biolegend \\
    209 Bi & CD11b & ICRF44 & Fluidigm \\
    194Pt & CD45 (acute BC) & HI130 & Biolegend \\
    198Pt  & CD45 (conv BC) & HI130 & Biolegend \\
    103 Rh  & Viability & n/a & Fluidigm \\
    191/193 Ir & DNA & n/a & Fluidigm \\
    \bottomrule
  \end{tabular}
\end{table*}

% Restore the geometry of tufte-latex's big right margin
\restoregeometry
% Restore tufte-latex's fancy header/footer offsets
\tuftefancyhfoffset

\clearpage
\newpage

% Recalculate fancy header/footer after geometry change (otherwise page numbers are misplaced)
%\fancyhfoffset[E,O]{0pt}
